Top Story

BLOG: Three predictions about presbyopia-correcting eye drops

March 18, 2019
Meeting News

iStent inject reduces IOP relative to starting pressure

March 18, 2019
SAN FRANCISCO — Decrease in IOP attributable to phacoemulsification “maxes out” regardless of starting baseline pressure, whereas the effect of the…

Alcon acquires PowerVision

March 18, 2019
Alcon has acquired PowerVision, the developer of fluid-based IOLs for cataract surgery patients, according to a press release. PowerVision’s presbyopia-correcting…
Meeting News

Kahook Dual Blade reduces IOP with and without phaco

March 18, 2019
SAN FRANCISCO — The Kahook Dual Blade procedure, with or without phacoemulsification, reduced IOP at 18 months, even more so in eyes with pseudoexfoliation…

Will a miotic agent or an agent that restores lens elasticity be more of an impactful pharmacologic therapy to treat presbyopia?

Ocular Surgery News U.S. Edition, March 25, 2019
Point One of these two pharmacologic approaches to the nonsurgical treatment of presbyopia includes PRX ophthalmic solution (Presbyopia Therapies). PRX eye drops are…
More Headlines »
Original Article

Postoperative Corneal Complications in Small Incision Lenticule Extraction: Long-Term Study

Journal of Refractive Surgery, March 2019, Volume 35 Issue 3
To investigate the incidence and clinical results of corneal complications after small incision lenticule extraction…
More »

Cataract and Refractive 360—Fundamentals, Techniques, & Technology; Volume 3, Number 4

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; and J & J Vision.

Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment…
More »
Resource Centers
Meeting News

VIDEO: Remotely controlled slit lamp could benefit Greek population living on islands

March 1, 2019
More »